IE40745B1 - Cephem derivatives and preparation thereof - Google Patents

Cephem derivatives and preparation thereof

Info

Publication number
IE40745B1
IE40745B1 IE2113/74A IE211374A IE40745B1 IE 40745 B1 IE40745 B1 IE 40745B1 IE 2113/74 A IE2113/74 A IE 2113/74A IE 211374 A IE211374 A IE 211374A IE 40745 B1 IE40745 B1 IE 40745B1
Authority
IE
Ireland
Prior art keywords
substituted
methyl
formula
tetrazolyl
phenyl
Prior art date
Application number
IE2113/74A
Other versions
IE40745L (en
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Priority to IE2179/77A priority Critical patent/IE40746B1/en
Priority to IE2180/77A priority patent/IE40747B1/en
Publication of IE40745L publication Critical patent/IE40745L/en
Publication of IE40745B1 publication Critical patent/IE40745B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

1481807 Cephem derivatives PFIZER Inc 14 Oct 1974 [17 Oct 1973] 44350/74 Heading C2C The invention comprises compounds of the formula and the salts thereof, wherein T is a tetrazoyl group which is either wherein R is an acyl group of the formula A is H, CH 3 COO, l-methyl-tetrazolyl-5-thio or 2 - methyl - 1,3,4 - thiadiazolyl - 5 - thio; R 1 is H, (C 3 -C 6 ) alkanoyloxymethyl, 1 - (C 4 -C 7 ) alkanoyloxyethyl, CH 3 OCH 2 - or phthalidyl and Rll is the same as R 1 or is a tetrazolyl cephem nitrogen protecting group or precursor thereof and is selected from and wherein R 6 is (C 1 -C 3 ) alkyl or phenyl, R 7 is OH, CH 3 O, (C 2 -C 4 ) alkanoyloxy or benzyloxy, R 8 is H, OH, F, Cl, Br, I, CH 3 , CH 3 O, (C 2 -C 4 ) alkanoyloxy, phenyl or benzyloxy, R 9 and R 10 are each H or CH 3 and X is O or S; Ar is cyano, bromo, phenyl, mono- or disubstituted phenyl where each substituent is hydroxy, fluoro, chloro, bromo, amino, methoxy, or methyl, phenoxy, phenylthio, pyridylthio, thienyl, 2- methyl - 1,3,4 - thiadiazol - 5 - ylthio, 1 - tetrazolyl, (C 1 -C 12 ) alkyl, (C 2 -C 12 ) alkenyl, (C 3 - C,) cycloalkyl, (C 5 -C 8 ) cycloalkenyl, cycloheptatrienyl, 1,4 - cyclohexadienyl, 1 - amino (C 4 -C 7 ) cycloalkyl, 5 - methyl - 3 - phenyl - 4- isoxazolyl; 5 - methyl - 3 - (o - chlorophenyl)- 4 - isoxazolyl, 5 - methyl - 3 - (2,6 - dichlorophenyl) - 4 - isoxazolyl, 5 - methyl - 3 - (2- chloro - 6 - fluorophenyl) - 4 - isoxazolyl, 2- (C 1 -C 4 ) alkoxy-1-naphthyl, sydnonyl, furyl, pyridyl, thiazolyl, isothiazolyl, pyrimidinyl, triazolyl, imidazolyl, pyrazolyl, substituted phenoxy, substituted phenylthio, substituted pyridylthio, substituted thienyl, substituted furyl, substituted pyridyl, substituted tetrazolyl, substituted thiazolyl, substituted isothiazolyl, substituted pyrimidinyl, substituted triazolyl, substituted imidazolyl or substituted pyrazolyl, each substituted moiety being substituted by up to two of fluoro, chloro, bromo, hydroxy, hydroxymethyl, amino, N,N-di (C 1 - C 4 ) alkylamino, (C 1 -C 4 ) alkyl, aminomethyl, aminoethyl, (C 1 -C 4 ) alkoxy, (C 1 -C 4 ) alkylthio, 2-aminoethoxy and N-(C 1 -C 4 ) alkylamino, Q is hydrogen, hydroxy, azido, amino or carboxy ; n is an integer of 0 or 1; provided that when Ar is pyridylthio, phenoxy, phenylthio, 2 - methyl - 1,3,3 - thiadiazol - 5 - ylthio, bromo or cyano and n is 1, Q is hydrogen or carboxy. They may be obtained by (1) acylating a compound of Formula I wherein R is replaced by H with an acid halide, an activated ester or a mixed anhydride of a carboxylic acid, or a mixture of a carboxylic acid and a carbodiimide to give R as an acyl group of the above formula; and (2) reacting a compound of Formula I where T is replaced by -CONHR 2 wherein R 2 is selected from groups of Formulµ III and IV above, with a chlorinating agent to produce an imino chloride followed by reaction with an azide to form a tetrazolyl group, optionally replacing the R 2 group by treatment with a mixture of CF 3 COOH and anisole. Pharmaceutical compositions comprise the compounds of Formula I above as antibacterial agents together with a pharmaceutical carrier, and may be administered orally, e.g. by way of animal feed supplements, or parenterally. [GB1481807A]
IE2113/74A 1973-10-17 1974-10-14 Cephem derivatives and preparation thereof IE40745B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE2179/77A IE40746B1 (en) 1973-10-17 1974-10-14 Cephem derivatives and preparation thereof
IE2180/77A IE40747B1 (en) 1973-10-17 1974-10-14 Cephem derivatives and preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US40709773A 1973-10-17 1973-10-17

Publications (2)

Publication Number Publication Date
IE40745L IE40745L (en) 1975-04-17
IE40745B1 true IE40745B1 (en) 1979-08-15

Family

ID=23610572

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2113/74A IE40745B1 (en) 1973-10-17 1974-10-14 Cephem derivatives and preparation thereof

Country Status (22)

Country Link
JP (3) JPS50121293A (en)
AR (2) AR209283A1 (en)
BE (1) BE821164A (en)
CA (1) CA1064019A (en)
DD (1) DD114266A5 (en)
DE (1) DE2449834A1 (en)
DK (1) DK542174A (en)
ES (4) ES431069A1 (en)
FR (1) FR2257298B1 (en)
GB (4) GB1481807A (en)
IE (1) IE40745B1 (en)
IL (1) IL45849A0 (en)
LU (1) LU71128A1 (en)
MW (2) MW4174A1 (en)
NL (1) NL7413643A (en)
NO (1) NO743667L (en)
OA (1) OA04935A (en)
PL (1) PL95747B1 (en)
SE (2) SE429342B (en)
SU (1) SU974936A3 (en)
ZA (1) ZA746544B (en)
ZM (1) ZM16174A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9334289B2 (en) * 2011-04-28 2016-05-10 Shionogi & Co., Ltd. Cephem compound having catechol or pseudo-catechol structure
US9242999B2 (en) 2011-06-27 2016-01-26 Shionogi & Co., Ltd. Cephem compound having pyridinium group

Also Published As

Publication number Publication date
IE40745L (en) 1975-04-17
MW4074A1 (en) 1976-01-14
ES450399A1 (en) 1977-08-16
DD114266A5 (en) 1975-07-20
ES450397A1 (en) 1977-08-16
FR2257298B1 (en) 1978-06-30
AR213726A1 (en) 1979-03-15
ES431069A1 (en) 1977-02-01
JPS5822480B2 (en) 1983-05-09
NO743667L (en) 1975-05-12
CA1064019A (en) 1979-10-09
GB1481810A (en) 1977-08-03
SE7710697L (en) 1977-09-23
MW4174A1 (en) 1976-06-09
JPS58131988A (en) 1983-08-06
NL7413643A (en) 1975-04-21
DE2449834A1 (en) 1975-04-30
AR209283A1 (en) 1977-04-15
ZA746544B (en) 1975-10-29
SE429342B (en) 1983-08-29
GB1481808A (en) 1977-08-03
AU7442574A (en) 1976-04-29
LU71128A1 (en) 1975-06-24
SU974936A3 (en) 1982-11-15
FR2257298A1 (en) 1975-08-08
OA04935A (en) 1980-10-31
SE7412602L (en) 1975-04-18
JPS57145882A (en) 1982-09-09
PL95747B1 (en) 1977-11-30
DK542174A (en) 1975-06-16
ZM16174A1 (en) 1975-06-23
BE821164A (en) 1975-04-17
GB1481807A (en) 1977-08-03
ES450398A1 (en) 1977-09-01
IL45849A0 (en) 1974-12-31
GB1481809A (en) 1977-08-03
JPS50121293A (en) 1975-09-23

Similar Documents

Publication Publication Date Title
SU1026654A3 (en) Process for preparing esters of 1,1-dioxide of 6beta-hydroxymethylpenicillanic acid
GB1456221A (en) 3-hydroxy cephalosporins their ether derivatives and methods for their preparation
GB1505885A (en) Substituted cephalosporins
NO802682L (en) PROCEDURE FOR PREPARING A SYNERGISTIC PHARMACEUTICAL PREPARATION.
US4263280A (en) Synergistic mixtures
IE40745B1 (en) Cephem derivatives and preparation thereof
US4061748A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US4117126A (en) 7-(α-(4-Hydroxy-1,5-naphthyridine-3-carbonamido)-α-phenylacetamido) cephalosporin derivatives
US3928595A (en) Dipenicillin and dicephalosporin ester antibiotics
US4426377A (en) Clavulanic acid derivatives their preparation and use
DE3166235D1 (en) Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
DE3041160A1 (en) 1-OXADETHIA-CEPHALOSPORIN DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND ANTIBACTERIAL AGENTS CONTAINING THESE COMPOUNDS
US4046904A (en) Novel penicillin, and its preparation and use
US4388300A (en) Clavulanic acid derivatives, a process for their preparation and their use in pharmaceutical compositions
US4534968A (en) Pharmaceutical compositions
KR900004418B1 (en) Process for preparing penem esters
GB1562902A (en) Pharmaceutical compositions containing clavulanic acid
JPS61191685A (en) Carbapenems bonded with alkylene hetero atom bridge and having 2-position substituent
US4303665A (en) Methylaminodeoxy-clavulanic acid derivatives, their production and use
US4203972A (en) Penicillin composition
EP0112685B1 (en) Compounds containing beta-lactams
US4390535A (en) Antimicrobial 7-(α-acylamino-α-arylacetamido)-3-(substituted methyl)cephalosporin compounds
EP0050932B1 (en) Therapeutic compounds containing beta-lactams
US4221781A (en) Synergistic penicillin-cephalosporin compositions and methods
US4197402A (en) Cephalosporin analogues